Online Only Articles

Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance

Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, the Netherlands
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Hematology, University Medical Center Utrecht, the Netherlands
Department of Hematology, University Medical Center Utrecht, the Netherlands
Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, the Netherlands
Janssen Research & Development, Spring House, PA, USA
Janssen Research & Development, Spring House, PA, USA
Xpand Biotechnology BV, Bilthoven, the Netherlands
Xpand Biotechnology BV, Bilthoven, the Netherlands
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, the Netherlands;Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Vol. 101 No. 8 (2016): August, 2016 https://doi.org/10.3324/haematol.2015.139667